Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics

被引:22
|
作者
Blanchard, Helen [1 ]
Bum-Erdene, Khuchtumur [1 ]
Hugo, Matthew W. [1 ]
机构
[1] Griffith Univ, Inst Glyc, Gold Coast Campus, Qld 4222, Australia
关键词
MODIFIED CITRUS PECTIN; CYCLODEXTRIN-BASED GLYCOCLUSTERS; ARGININE-ARENE INTERACTIONS; PROSTATE-CANCER; MAMMALIAN GALECTINS; TETRAVALENT GLYCOCLUSTERS; INDUCED APOPTOSIS; CELL APOPTOSIS; MESSENGER-RNA; TUMOR-GROWTH;
D O I
10.1071/CH14362
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Galectins are a family of galactoside-specific lectins that are involved in a myriad of metabolic and disease processes. Due to roles in cancer and inflammatory and heart diseases, galectins are attractive targets for drug development. Over the last two decades, various strategies have been used to inhibit galectins, including polysaccharide-based therapeutics, multivalent display of saccharides, peptides, peptidomimetics, and saccharide-modifications. Primarily due to galectin carbohydrate binding sites having high sequence identities, the design and development of selective inhibitors targeting particular galectins, thereby addressing specific disease states, is challenging. Furthermore, the use of different inhibition assays by research groups has hindered systematic assessment of the relative selectivity and affinity of inhibitors. This review summarises the status of current inhibitors, strategies, and novel scaffolds that exploit subtle differences in galectin structures that, in conjunction with increasing available data on multiple galectins, is enabling the feasible design of effective and specific inhibitors of galectins.
引用
收藏
页码:1763 / 1779
页数:17
相关论文
共 50 条
  • [31] STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE
    BABU, YS
    EALICK, SE
    BUGG, CE
    ERION, MD
    GUIDA, WC
    MONTGOMERY, JA
    SECRIST, JA
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 : 529 - 535
  • [32] Structure-based design of hepatitis C virus inhibitors
    Smith, RM
    Wu, GY
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (06) : 405 - 412
  • [33] Models of Ternary Complexes for Nonpeptidic Farnesyltransferase Inhibitors: Insights into Structure-Based Screen and Design of Potential Anticancer Therapeutics
    Kun Xu
    Emanuele Perola
    Franklyn G. Prendergast
    Yuan-Ping Pang
    Molecular modeling annual, 1999, 5 : 203 - 217
  • [34] DESIGN OF STRUCTURE-BASED REVERSE-TRANSCRIPTASE INHIBITORS
    KANG, I
    WANG, JH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (16) : 12024 - 12031
  • [35] Models of ternary complexes for nonpeptidic farnesyltransferase inhibitors: Insights into structure-based screen and design of potential anticancer therapeutics
    Xu, K
    Perola, E
    Prendergast, FG
    Pang, YP
    JOURNAL OF MOLECULAR MODELING, 1999, 5 (10) : 203 - 217
  • [36] Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design
    Meng, Fei
    Hou, Jing
    Shao, Yong-Xian
    Wu, Pei-Ying
    Huang, Manna
    Zhu, Xinhai
    Cai, Yonghong
    Li, Zhe
    Xu, Jie
    Liu, Peiqing
    Luo, Hai-Bin
    Wan, Yiqian
    Ke, Hengming
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8549 - 8558
  • [37] STRUCTURE-BASED DESIGN OF NONPEPTIDE INHIBITORS SPECIFIC FOR THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE
    DESJARLAIS, RL
    SEIBEL, GL
    KUNTZ, ID
    FURTH, PS
    ALVAREZ, JC
    DEMONTELLANO, PRO
    DECAMP, DL
    BABE, LM
    CRAIK, CS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6644 - 6648
  • [38] Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells
    Katunuma, N
    Tsuge, H
    Nukatsuka, M
    Asao, T
    Fukushima, M
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) : 305 - 311
  • [39] Structure-based design of novel potent nonpeptide thrombin inhibitors
    Hauel, NH
    Nar, H
    Priepke, H
    Ries, U
    Stassen, JM
    Wienen, W
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1757 - 1766
  • [40] Structure-based design of allosteric K-Ras inhibitors
    Gorfe, Alemayehu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253